Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medx Health's Enterprise Value is $17.90 Mil.
Medx Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.08 Mil. Therefore, Medx Health's EV-to-EBIT ratio for today is -5.82.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medx Health's Enterprise Value is $17.90 Mil.
Medx Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.03 Mil. Therefore, Medx Health's EV-to-EBITDA ratio for today is -5.90.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Medx Health's Enterprise Value is $17.90 Mil.
Medx Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $0.39 Mil. Therefore, Medx Health's EV-to-Revenue ratio for today is 45.56.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Medx Health's Enterprise Value is $17.90 Mil.
Medx Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.94 Mil. Therefore, Medx Health's EV-to-FCF ratio for today is -6.10.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Medx Health (OTCPK:MDXHF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Medx Health's current Enterprise Value is $17.90 Mil.
Medx Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.08 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Medx Health's current Enterprise Value is $17.90 Mil.
Medx Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.03 Mil.
Medx Health's current Enterprise Value is $17.90 Mil.
Medx Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.39 Mil.
Medx Health's current Enterprise Value is $17.90 Mil.
Medx Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.94 Mil.
Medx Health's current Enterprise Value is $17.90 Mil.
Medx Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medx Health Enterprise Value Related Terms
Medx Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for Medx Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDXHF vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Medx Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medx Health Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Medx Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Medx Health's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medx Health (MDXHF) has a Enterprise Value of $17.90 Mil as of Jul. 05, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medx Health and its competitors.
Is Medx Health's Enterprise Value too high?
Medx Health's current Enterprise Value is $17.90 Mil.
How does Medx Health's Enterprise Value compare to ABT and SYK?
Medx Health's Enterprise Value of $17.90 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medx Health and its competitors. Medx Health's current Enterprise Value is $17.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medx Health stock overvalued right now?
Based on GuruFocus' analysis, Medx Health (MDXHF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 20% above its estimated fair value. The current Enterprise Value is $17.90 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Medx Health (MDXHF), the current Enterprise Value is $17.90 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medx Health Corp is engaged in the development, manufacturing, and marketing skin-related screening tools and phototherapy devices for pain relief and tissue repair, marketing the latter in Canada and the United States while the skin related screening tools are also marketed in Europe, Australia and selected markets in Latin America. It offers DermSecure, and MedX Laser Therapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDXHF has been successfully added to your 